Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02639910
Title Study to Evaluate Efficacy and Safety of MOR208 With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi (COSMOS)
Acronym COSMOS
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors MorphoSys AG
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | DEU | AUT

No variant requirements are available.